Skip to content
naulon

Not checkedNot checked for notices yet.

NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus

Hans D. Brightbill, Eric Suto, Nicole Blaquiere and 32 more

Nature Communications · 2018

doi:10.1038/s41467-017-02672-0 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Clinical trials of BAFF blockade with belimumab have shown partial efficacy for the treatment of systemic lupus erythematosus (SLE), so other therapeutic options are required. Here, the authors present a new small molecule inhibitor that targets NIK with a similar efficacy to BAFF inhibition in two mouse models of SLE.

Abstract licence: CC BY-NC-ND

Cited by papers we hold3

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.